Market Executive Summary
The global Immuno-oncology Drugs market was valued at 530.56 Million USD in 2021 and will grow with a CAGR of 14.11% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
By Types:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
By Applications:
Hospitals
Pharmacies
Online Pharmacies
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-oncology Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-oncology Drugs Market Share by Application: 2022-2027
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immuno-oncology Drugs Market
1.8.1 Global Immuno-oncology Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Immuno-oncology Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Immuno-oncology Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Immuno-oncology Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Immuno-oncology Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Immuno-oncology Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Immuno-oncology Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Immuno-oncology Drugs Sales Volume
3.3.1 North America Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Immuno-oncology Drugs Sales Volume
3.4.1 East Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Immuno-oncology Drugs Sales Volume (2016-2021)
3.5.1 Europe Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Immuno-oncology Drugs Sales Volume (2016-2021)
3.6.1 South Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Immuno-oncology Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Immuno-oncology Drugs Sales Volume (2016-2021)
3.8.1 Middle East Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Immuno-oncology Drugs Sales Volume (2016-2021)
3.9.1 Africa Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Immuno-oncology Drugs Sales Volume (2016-2021)
3.10.1 Oceania Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Immuno-oncology Drugs Sales Volume (2016-2021)
3.11.1 South America Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Immuno-oncology Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Immuno-oncology Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Immuno-oncology Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Immuno-oncology Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Immuno-oncology Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Immuno-oncology Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Immuno-oncology Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Immuno-oncology Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Immuno-oncology Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Immuno-oncology Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Immuno-oncology Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Immuno-oncology Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Immuno-oncology Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Immuno-oncology Drugs Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Immuno-oncology Drugs Consumption Volume by Application (2016-2021)
15.2 Global Immuno-oncology Drugs Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Immuno-oncology Drugs Business
16.1 Amgen, Inc
16.1.1 Amgen, Inc Company Profile
16.1.2 Amgen, Inc Immuno-oncology Drugs Product Specification
16.1.3 Amgen, Inc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 AstraZeneca, Plc
16.2.1 AstraZeneca, Plc Company Profile
16.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Specification
16.2.3 AstraZeneca, Plc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Bristol-Myers Squibb
16.3.1 Bristol-Myers Squibb Company Profile
16.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Specification
16.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Celgene Corporation
16.4.1 Celgene Corporation Company Profile
16.4.2 Celgene Corporation Immuno-oncology Drugs Product Specification
16.4.3 Celgene Corporation Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Eli Lilly and Company
16.5.1 Eli Lilly and Company Company Profile
16.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Specification
16.5.3 Eli Lilly and Company Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Merck & Co.
16.6.1 Merck & Co. Company Profile
16.6.2 Merck & Co. Immuno-oncology Drugs Product Specification
16.6.3 Merck & Co. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Hoffmann-La Roche AG
16.7.1 Hoffmann-La Roche AG Company Profile
16.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Specification
16.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Johnson & Johnson
16.8.1 Johnson & Johnson Company Profile
16.8.2 Johnson & Johnson Immuno-oncology Drugs Product Specification
16.8.3 Johnson & Johnson Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Novartis International AG
16.9.1 Novartis International AG Company Profile
16.9.2 Novartis International AG Immuno-oncology Drugs Product Specification
16.9.3 Novartis International AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 AbbVie, Inc.
16.10.1 AbbVie, Inc. Company Profile
16.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Specification
16.10.3 AbbVie, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Pfizer Inc.
16.11.1 Pfizer Inc. Company Profile
16.11.2 Pfizer Inc. Immuno-oncology Drugs Product Specification
16.11.3 Pfizer Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Sanofi S.A.
16.12.1 Sanofi S.A. Company Profile
16.12.2 Sanofi S.A. Immuno-oncology Drugs Product Specification
16.12.3 Sanofi S.A. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 EMD Serono, Inc.
16.13.1 EMD Serono, Inc. Company Profile
16.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Specification
16.13.3 EMD Serono, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Gilead Sciences Inc.
16.14.1 Gilead Sciences Inc. Company Profile
16.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Specification
16.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Prometheus Therapeutics & Diagnostics
16.15.1 Prometheus Therapeutics & Diagnostics Company Profile
16.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Specification
16.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Aduro BioTech
16.16.1 Aduro BioTech Company Profile
16.16.2 Aduro BioTech Immuno-oncology Drugs Product Specification
16.16.3 Aduro BioTech Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Galena Biopharma
16.17.1 Galena Biopharma Company Profile
16.17.2 Galena Biopharma Immuno-oncology Drugs Product Specification
16.17.3 Galena Biopharma Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Bavarian Nordic
16.18.1 Bavarian Nordic Company Profile
16.18.2 Bavarian Nordic Immuno-oncology Drugs Product Specification
16.18.3 Bavarian Nordic Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Celldex Therapeutics
16.19.1 Celldex Therapeutics Company Profile
16.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Specification
16.19.3 Celldex Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 ImmunoCellular Therapeutics
16.20.1 ImmunoCellular Therapeutics Company Profile
16.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Specification
16.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 Incyte
16.21.1 Incyte Company Profile
16.21.2 Incyte Immuno-oncology Drugs Product Specification
16.21.3 Incyte Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Immuno-oncology Drugs Manufacturing Cost Analysis
17.1 Immuno-oncology Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Immuno-oncology Drugs
17.4 Immuno-oncology Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Immuno-oncology Drugs Distributors List
18.3 Immuno-oncology Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Immuno-oncology Drugs (2022-2027)
20.2 Global Forecasted Revenue of Immuno-oncology Drugs (2022-2027)
20.3 Global Forecasted Price of Immuno-oncology Drugs (2016-2027)
20.4 Global Forecasted Production of Immuno-oncology Drugs by Region (2022-2027)
20.4.1 North America Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Immuno-oncology Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Immuno-oncology Drugs by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Immuno-oncology Drugs by Country
21.2 East Asia Market Forecasted Consumption of Immuno-oncology Drugs by Country
21.3 Europe Market Forecasted Consumption of Immuno-oncology Drugs by Countriy
21.4 South Asia Forecasted Consumption of Immuno-oncology Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Immuno-oncology Drugs by Country
21.6 Middle East Forecasted Consumption of Immuno-oncology Drugs by Country
21.7 Africa Forecasted Consumption of Immuno-oncology Drugs by Country
21.8 Oceania Forecasted Consumption of Immuno-oncology Drugs by Country
21.9 South America Forecasted Consumption of Immuno-oncology Drugs by Country
21.10 Rest of the world Forecasted Consumption of Immuno-oncology Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
List of Figures
Key Players Covered: Ranking by Immuno-oncology Drugs Revenue (US$ Million) 2016-2021
Global Immuno-oncology Drugs Market Size by Type (US$ Million): 2022-2027
Global Immuno-oncology Drugs Market Size by Application (US$ Million): 2022-2027
Global Immuno-oncology Drugs Production Capacity by Manufacturers
Global Immuno-oncology Drugs Production by Manufacturers (2016-2021)
Global Immuno-oncology Drugs Production Market Share by Manufacturers (2016-2021)
Global Immuno-oncology Drugs Revenue by Manufacturers (2016-2021)
Global Immuno-oncology Drugs Revenue Share by Manufacturers (2016-2021)
Global Market Immuno-oncology Drugs Average Price of Key Manufacturers (2016-2021)
Manufacturers Immuno-oncology Drugs Production Sites and Area Served
Manufacturers Immuno-oncology Drugs Product Type
Global Immuno-oncology Drugs Sales Volume by Region (2016-2021)
Global Immuno-oncology Drugs Sales Volume Market Share by Region (2016-2021)
Global Immuno-oncology Drugs Sales Revenue by Region (2016-2021)
Global Immuno-oncology Drugs Sales Revenue Market Share by Region (2016-2021)
North America Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Immuno-oncology Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Immuno-oncology Drugs Consumption by Countries (2016-2021)
East Asia Immuno-oncology Drugs Consumption by Countries (2016-2021)
Europe Immuno-oncology Drugs Consumption by Region (2016-2021)
South Asia Immuno-oncology Drugs Consumption by Countries (2016-2021)
Southeast Asia Immuno-oncology Drugs Consumption by Countries (2016-2021)
Middle East Immuno-oncology Drugs Consumption by Countries (2016-2021)
Africa Immuno-oncology Drugs Consumption by Countries (2016-2021)
Oceania Immuno-oncology Drugs Consumption by Countries (2016-2021)
South America Immuno-oncology Drugs Consumption by Countries (2016-2021)
Rest of the World Immuno-oncology Drugs Consumption by Countries (2016-2021)
Global Immuno-oncology Drugs Sales Volume by Type (2016-2021)
Global Immuno-oncology Drugs Sales Volume Market Share by Type (2016-2021)
Global Immuno-oncology Drugs Sales Revenue by Type (2016-2021)
Global Immuno-oncology Drugs Sales Revenue Share by Type (2016-2021)
Global Immuno-oncology Drugs Sales Price by Type (2016-2021)
Global Immuno-oncology Drugs Consumption Volume by Application (2016-2021)
Global Immuno-oncology Drugs Consumption Volume Market Share by Application (2016-2021)
Global Immuno-oncology Drugs Consumption Value by Application (2016-2021)
Global Immuno-oncology Drugs Consumption Value Market Share by Application (2016-2021)
Amgen, Inc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AstraZeneca, Plc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bristol-Myers Squibb Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Celgene Corporation Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly and Company Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Merck & Co. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Hoffmann-La Roche AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Johnson & Johnson Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novartis International AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AbbVie, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi S.A. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
EMD Serono, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Gilead Sciences Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Aduro BioTech Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Galena Biopharma Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bavarian Nordic Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Celldex Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
ImmunoCellular Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Incyte Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Immuno-oncology Drugs Distributors List
Immuno-oncology Drugs Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Immuno-oncology Drugs Production Forecast by Region (2022-2027)
Global Immuno-oncology Drugs Sales Volume Forecast by Type (2022-2027)
Global Immuno-oncology Drugs Sales Volume Market Share Forecast by Type (2022-2027)
Global Immuno-oncology Drugs Sales Revenue Forecast by Type (2022-2027)
Global Immuno-oncology Drugs Sales Revenue Market Share Forecast by Type (2022-2027)
Global Immuno-oncology Drugs Sales Price Forecast by Type (2022-2027)
Global Immuno-oncology Drugs Consumption Volume Forecast by Application (2022-2027)
Global Immuno-oncology Drugs Consumption Value Forecast by Application (2022-2027)
North America Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
East Asia Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Europe Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
South Asia Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Southeast Asia Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Middle East Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Africa Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Oceania Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
South America Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Rest of the world Immuno-oncology Drugs Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Immuno-oncology Drugs Market Share by Type: 2021 VS 2027
Immune Checkpoint Inhibitors Features
Monoclonal Antibodies Features
Cytokine-Based Immunotherapy Features
Cancer Vaccines Features
CAR-T Cell Therapy Features
Global Immuno-oncology Drugs Market Share by Application: 2021 VS 2027
Hospitals Case Studies
Pharmacies Case Studies
Online Pharmacies Case Studies
Immuno-oncology Drugs Report Years Considered
Global Immuno-oncology Drugs Market Status and Outlook (2016-2027)
North America Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
East Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
Europe Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
South Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
Middle East Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
Africa Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
Oceania Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Immuno-oncology Drugs Revenue (Value) and Growth Rate (2016-2027)
North America Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
East Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Europe Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
South Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Southeast Asia Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Middle East Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Africa Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Oceania Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
South America Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
Rest of the World Immuno-oncology Drugs Sales Volume Growth Rate (2016-2021)
North America Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
North America Immuno-oncology Drugs Consumption Market Share by Countries in 2021
United States Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Canada Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Mexico Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
East Asia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
East Asia Immuno-oncology Drugs Consumption Market Share by Countries in 2021
China Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Japan Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
South Korea Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Europe Immuno-oncology Drugs Consumption and Growth Rate
Europe Immuno-oncology Drugs Consumption Market Share by Region in 2021
Germany Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
United Kingdom Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
France Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Italy Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Russia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Spain Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Netherlands Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Switzerland Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Poland Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
South Asia Immuno-oncology Drugs Consumption and Growth Rate
South Asia Immuno-oncology Drugs Consumption Market Share by Countries in 2021
India Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Pakistan Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Bangladesh Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Southeast Asia Immuno-oncology Drugs Consumption and Growth Rate
Southeast Asia Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Indonesia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Thailand Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Singapore Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Malaysia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Philippines Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Vietnam Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Myanmar Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Middle East Immuno-oncology Drugs Consumption and Growth Rate
Middle East Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Turkey Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Saudi Arabia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Iran Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
United Arab Emirates Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Israel Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Iraq Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Qatar Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Kuwait Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Oman Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Africa Immuno-oncology Drugs Consumption and Growth Rate
Africa Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Nigeria Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
South Africa Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Egypt Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Algeria Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Morocco Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Oceania Immuno-oncology Drugs Consumption and Growth Rate
Oceania Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Australia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
New Zealand Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
South America Immuno-oncology Drugs Consumption and Growth Rate
South America Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Brazil Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Argentina Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Columbia Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Chile Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Venezuelal Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Peru Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Puerto Rico Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Ecuador Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Rest of the World Immuno-oncology Drugs Consumption and Growth Rate
Rest of the World Immuno-oncology Drugs Consumption Market Share by Countries in 2021
Kazakhstan Immuno-oncology Drugs Consumption and Growth Rate (2016-2021)
Sales Market Share of Immuno-oncology Drugs by Type in 2021
Sales Revenue Market Share of Immuno-oncology Drugs by Type in 2021
Global Immuno-oncology Drugs Consumption Volume Market Share by Application in 2021
Amgen, Inc Immuno-oncology Drugs Product Specification
AstraZeneca, Plc Immuno-oncology Drugs Product Specification
Bristol-Myers Squibb Immuno-oncology Drugs Product Specification
Celgene Corporation Immuno-oncology Drugs Product Specification
Eli Lilly and Company Immuno-oncology Drugs Product Specification
Merck & Co. Immuno-oncology Drugs Product Specification
Hoffmann-La Roche AG Immuno-oncology Drugs Product Specification
Johnson & Johnson Immuno-oncology Drugs Product Specification
Novartis International AG Immuno-oncology Drugs Product Specification
AbbVie, Inc. Immuno-oncology Drugs Product Specification
Pfizer Inc. Immuno-oncology Drugs Product Specification
Sanofi S.A. Immuno-oncology Drugs Product Specification
EMD Serono, Inc. Immuno-oncology Drugs Product Specification
Gilead Sciences Inc. Immuno-oncology Drugs Product Specification
Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Specification
Aduro BioTech Immuno-oncology Drugs Product Specification
Galena Biopharma Immuno-oncology Drugs Product Specification
Bavarian Nordic Immuno-oncology Drugs Product Specification
Celldex Therapeutics Immuno-oncology Drugs Product Specification
ImmunoCellular Therapeutics Immuno-oncology Drugs Product Specification
Incyte Immuno-oncology Drugs Product Specification
Manufacturing Cost Structure of Immuno-oncology Drugs
Manufacturing Process Analysis of Immuno-oncology Drugs
Immuno-oncology Drugs Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Immuno-oncology Drugs Production Capacity Growth Rate Forecast (2022-2027)
Global Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Global Immuno-oncology Drugs Price and Trend Forecast (2016-2027)
North America Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
North America Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
East Asia Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
East Asia Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Europe Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Europe Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
South Asia Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
South Asia Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Southeast Asia Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Middle East Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Middle East Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Africa Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Africa Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Oceania Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Oceania Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
South America Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
South America Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
Rest of the World Immuno-oncology Drugs Production Growth Rate Forecast (2022-2027)
Rest of the World Immuno-oncology Drugs Revenue Growth Rate Forecast (2022-2027)
North America Immuno-oncology Drugs Consumption Forecast 2022-2027
East Asia Immuno-oncology Drugs Consumption Forecast 2022-2027
Europe Immuno-oncology Drugs Consumption Forecast 2022-2027
South Asia Immuno-oncology Drugs Consumption Forecast 2022-2027
Southeast Asia Immuno-oncology Drugs Consumption Forecast 2022-2027
Middle East Immuno-oncology Drugs Consumption Forecast 2022-2027
Africa Immuno-oncology Drugs Consumption Forecast 2022-2027
Oceania Immuno-oncology Drugs Consumption Forecast 2022-2027
South America Immuno-oncology Drugs Consumption Forecast 2022-2027
Rest of the world Immuno-oncology Drugs Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
